Publication | Closed Access
Multicentre Real-world Experience of Upadacitinib in the Treatment of Crohn’s Disease
37
Citations
20
References
2022
Year
In this real-world cohort of highly refractory CD patients, upadacitinib was effective in inducing remission and had an acceptable safety profile.
| Year | Citations | |
|---|---|---|
Page 1
Page 1